Medical News

RSS

Consumers are not insured until they pay 1st premium

CNN cautions that it's not enough to sign up for a health law policy -- you need to make that first payment to your insurer. Elsewhere, ProPublica looks at healthcare.gov's back-end system to provide your sign-up information to insurers, and the Obama administration awards $55 million in grants to bolster the health care workforce.

6 Dec 2013

Kolltan Pharmaceuticals signs license agreement with University of Toronto for novel anti-KIT antibodies

Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced the Company has signed a license agreement with the University of Toronto for novel anti-KIT receptor tyrosine kinase antibodies identified in the laboratories of Dr. Sachdev Sidhu at the University of Toronto and the laboratory of Dr. Joseph Schlessinger of Yale University.

6 Dec 2013

Huntsville Hospital Health System chooses Caradigm HIE for integrated care across community

Huntsville Hospital Health System, the nation's fifth largest publicly owned healthcare organization, has selected the Caradigm Health Information Exchange, powered by Orion Health, to provide the backbone for integrated care across the community, with a vision to ultimately connect care across the entire northern Alabama region.

6 Dec 2013

Ancon Technologies unveils new cancer-screening device

Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.

6 Dec 2013

C4 Imaging receives FDA clearance for Sirius MRI Marker

C4 Imaging LLC is pleased to announce U.S. Food and Drug Administration 510(k) clearance of its first product, the Sirius™ MRI Marker. The novel Positive-Signal MRI Marker will be used following treatment of prostate cancer with brachytherapy to facilitate seed localization within the prostate, utilizing a single post-implant Magnetic Resonance imaging procedure.

6 Dec 2013

ATS Labs offers testing of antimicrobial products for efficacy against H7N9 virus

ATS Labs announced today that they are pleased to offer testing of antimicrobial products for efficacy against avian influenza A (H7N9) virus. Avian influenza A (H7N9) virus, called H7N9 for short, has infected humans in China causing severe respiratory illness.

6 Dec 2013

Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.

6 Dec 2013

Maternal weight issues spell wheezing trouble for children

High maternal weight and gestational weight gain are independently associated with an increased risk for wheezing in preschool age children, a Dutch study has found.

6 Dec 2013

Brain network disruption crosses psychosis diagnostic boundaries

Disruption of cortical information processing occurs in patients with psychosis regardless of whether they have a psychotic or affective diagnosis, research shows.

6 Dec 2013

Inflexible thinking in ADHD blamed on bipolar disorder

Impaired cognitive flexibility in patients with attention deficit hyperactivity disorder (ADHD) may be entirely due to the presence of comorbid bipolar disorder, say researchers.

6 Dec 2013

Imported measles poses a threat to health security

Experts report that measles still poses a threat to public health in the U.S, despite vaccination having successfully eliminated the endemic since the 1960s.

6 Dec 2013

ALS TDI forms research partnership with Neurimmune to advance potential treatments for ALS

The ALS Therapy Development Institute (ALS TDI), together with its wholly-owned subsidiary, Anelixis Therapeutics, announced today that it has formed a research partnership with Neurimmune to advance potential treatments for ALS, also known as Lou Gehrig's disease.

6 Dec 2013

New service helps hospitals and integrated delivery networks expand reach of outpatient pharmacies

At the annual Midyear Clinical Meeting of the American Society of Health-System Pharmacists (ASHP), Cardinal Health will launch a new service that helps hospitals and integrated delivery networks expand the reach of their outpatient pharmacies, while also generating additional revenue and freeing up pharmacist time to drive medication adherence and other quality measures.

6 Dec 2013

MELA Sciences participates in skin cancer diagnostic workshop in Germany

MELA Sciences, Inc., designer and developer of MelaFind®, an FDA and CE Mark approved non-invasive optical device that assists dermatologists in diagnosing melanoma at its most curable stage, participated in a two-day hands-on skin cancer diagnostics workshop in Augsburg, Germany, where leading dermatologists examined "high-risk" melanoma patients with MelaFind® and also participated in an imaging devices exhibit.

6 Dec 2013

The Medicines Company, Boston Scientific announce co-promotion agreement for Promus PREMIER stent system

Boston Scientific Corporation and The Medicines Company announce a co-promotion agreement for the Boston Scientific Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System.

6 Dec 2013

Physicians Realty Trust prices public offering of 8,300,000 common shares

Physicians Realty Trust (the "Company") today announced the pricing of its public offering of 8,300,000 common shares of beneficial interest, at a price to the public of $11.50 per share, for a total of approximately $89.4 million of net proceeds after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. All of the shares are being offered by the Company.

6 Dec 2013

Emids Technologies announces joint investment of $13.3M by Baird Capital and Council Capital

emids Technologies announced today a joint investment of $13.3 million by Baird Capital's venture capital group of Chicago and Nashville, Tenn.-based Council Capital that will enable the company to build on its leading position in the provision of healthcare IT services and solutions.

6 Dec 2013

New research finds that H7N9 still mainly adapted for infecting birds, not humans

Avian influenza virus H7N9, which killed several dozen people in China earlier this year, has not yet acquired the changes needed to infect humans easily, according to a new study by scientists at The Scripps Research Institute. In contrast to some initial studies that had suggested that H7N9 poses an imminent risk of a global pandemic, the new research found, based on analyses of virus samples from the Chinese outbreak, that H7N9 is still mainly adapted for infecting birds, not humans.

6 Dec 2013

Aortic valve implantation does not impair mental capacity of patients

Aortic valve stenosis is the most frequent heart valve defect of older people in Europe - the cause is usually increasing calcification of this important valve. In patients at high and excessive risk, conventional cardiac surgery is often no therapeutic option.

6 Dec 2013

First Edition: December 6, 2103

Today's headlines include news about how both the federal and state-based health insurance websites are doing.

6 Dec 2013

Medical News

Consumers are not insured until they pay 1st premium

Kolltan Pharmaceuticals signs license agreement with University of Toronto for novel anti-KIT antibodies

Huntsville Hospital Health System chooses Caradigm HIE for integrated care across community

Ancon Technologies unveils new cancer-screening device

C4 Imaging receives FDA clearance for Sirius MRI Marker

ATS Labs offers testing of antimicrobial products for efficacy against H7N9 virus

Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

Maternal weight issues spell wheezing trouble for children

Brain network disruption crosses psychosis diagnostic boundaries

Inflexible thinking in ADHD blamed on bipolar disorder

Imported measles poses a threat to health security

ALS TDI forms research partnership with Neurimmune to advance potential treatments for ALS

New service helps hospitals and integrated delivery networks expand reach of outpatient pharmacies

MELA Sciences participates in skin cancer diagnostic workshop in Germany

The Medicines Company, Boston Scientific announce co-promotion agreement for Promus PREMIER stent system

Physicians Realty Trust prices public offering of 8,300,000 common shares

Emids Technologies announces joint investment of $13.3M by Baird Capital and Council Capital

New research finds that H7N9 still mainly adapted for infecting birds, not humans

Aortic valve implantation does not impair mental capacity of patients

First Edition: December 6, 2103

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News